Details of the Drug Combinations

General Information of This Drug (ID: DMMC45B)

Drug Name

Teriparatide DMMC45B

Synonyms

Forteo; Forteo (TN); Teriparatide (genetical recombination); Teriparatide (USAN/INN); Teriparatide (genetical recombination) (JAN)

Indication

Disease Entry	ICD 11	Status	REF
Exostosis	N.A.	Approved	[1]
Myelofibrosis	2A20.2	Approved	[1]
Osteogenesis imperfecta	LD24.K0	Approved	[2]
Osteoporosis	FB83.0	Approved	[1]
Psoriatic disorder	EA90	Discontinued in Phase 2	[3]
Autosomal dominant hypocalcemia	5A50.0Y	Investigative	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of Indication(s)

Therapeutic Class

Bone Density Conservation Agents

Drug Type

Peptide

Structure

3D MOL is unavailable

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

6 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Cinacalcet + Teriparatide	DCQET08	Cinacalcet	Kidney Failure, Chronic	[4]
Raloxifene + Teriparatide	DCWN3YJ	Raloxifene	Osteoporosis	[5]
Risedronate + Teriparatide	DCLN5KU	Risedronate	Osteoporosis	[6]
Teriparatide + Teriparatide	DCD3PZ2	Teriparatide	Osteoporosis	[7]
Teriparatide + Alendronate	DC25P1W	Alendronate	Osteoporosis	[8]
Zoledronate + Teriparatide	DC2G1YP	Zoledronate	Osteoporosis	[9]
------------------------------------------------------------------------------------


⏷ Show the Full List of 6 DrugCom(s)

References

1	Teriparatide FDA Label
2	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4448).
3	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030730)
4	ClinicalTrials.gov (NCT02440581) Renal Osteodystrophy: An Individual Management Approach
5	ClinicalTrials.gov (NCT01166958) Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?
6	ClinicalTrials.gov (NCT01611571) Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis
7	ClinicalTrials.gov (NCT00005006) Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
8	ClinicalTrials.gov (NCT00000400) Alendronate and/or Parathyroid Hormone for Osteoporosis
9	ClinicalTrials.gov (NCT00439244) Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis